These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16476806)

  • 1. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.
    Huang X; Chen P; Kaufer DI; Tröster AI; Poole C
    Arch Neurol; 2006 Feb; 63(2):189-93. PubMed ID: 16476806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
    Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
    Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
    Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
    Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls.
    Niu W; Qi Y; Qian Y; Gao P; Zhu D
    Hypertens Res; 2009 Dec; 32(12):1060-6. PubMed ID: 19816504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
    Feldman B; Chapman J; Korczyn AD
    Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
    Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
    Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease.
    Huang X; Chen PC; Poole C
    Neurology; 2004 Jun; 62(12):2198-202. PubMed ID: 15210882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
    Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
    Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease.
    Tröster AI; Fields JA; Paolo AM; Koller WC
    J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.
    López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME
    Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
    Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
    Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
    Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
    Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
    Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E gene polymorphism in a Chinese population with vascular dementia: a meta-analysis.
    Liu B; Shen Y; Cen L; Tang Y
    Dement Geriatr Cogn Disord; 2012; 33(2-3):96-103. PubMed ID: 22433749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
    Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
    Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia].
    Jasińska-Myga B; Opala G; Ochudło S; Tustanowski J
    Wiad Lek; 2004; 57(1-2):20-4. PubMed ID: 15181744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E Polymorphisms and Parkinson Disease With or Without Dementia: A Meta-Analysis Including 6453 Participants.
    Sun R; Yang S; Zheng B; Liu J; Ma X
    J Geriatr Psychiatry Neurol; 2019 Jan; 32(1):3-15. PubMed ID: 30526202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.